These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 29742598)

  • 1. Unicentric Castleman's Disease Revealed by 18F-FDG PET/CT and Somatostatin Receptor Scintigraphy With 99mTc-HYNIC-TOC.
    Luo Y; Wang L; Pan Q; Ma Y; Li F
    Clin Nucl Med; 2018 Jul; 43(7):551-552. PubMed ID: 29742598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Mixed Variant of Castleman Disease Detected by Somatostatin Receptor Scintigraphy with 99mTc-HYNIC-TOC and 18F-FDG PET/CT.
    Pan Q; Zhang X; Luo Y; Ma Y; Li F
    Clin Nucl Med; 2019 Feb; 44(2):164-166. PubMed ID: 30516666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenal Castleman Disease on 99mTc-HYNIC-TOC Scan and FDG PET/CT.
    Ding J; Cheng X; Hou G; Jing H; Huo L
    Clin Nucl Med; 2021 Jan; 46(1):71-73. PubMed ID: 32956111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of 99mTc-HYNIC-TOC and HYNIC-TATE octreotide scintigraphy with FDG PET and 99mTc-MIBI in local recurrent or distant metastatic thyroid cancers.
    Sager S; Kabasakal L; Halac M; Maecke H; Uslu L; Önsel Ç; Kanmaz B
    Clin Nucl Med; 2013 May; 38(5):321-5. PubMed ID: 23531772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Castleman's Disease of the Kidney Mimicking Renal Cell Carcinoma on FDG PET/CT.
    Wang Y; Dong A; Yang B; Lu J
    Clin Nucl Med; 2018 May; 43(5):e160-e163. PubMed ID: 29432340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypermetabolic Unicentric Castleman Disease of Kidney on FDG PET/CT.
    Wang P; Hou G; Li F; Cheng X
    Clin Nucl Med; 2021 Jun; 46(6):510-511. PubMed ID: 33939651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of PET/CT 68Ga somatostatin receptor imaging on proceeding with patients, who were previously diagnosed with 99mTc-EDDA/HYNIC-TOC SPECT.
    Madrzak D; Mikołajczak R; Kamiński G
    Nucl Med Rev Cent East Eur; 2016; 19(2):88-92. PubMed ID: 27479886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abdominal Castleman's disease with 18F-FDG PET/CT.
    Badenes Romero Á; Milà López M; Vallansot RO; Achury Murcia CA; Patricia Fierro Alanis M; Carrera Salazar D; Muro VI; Quintero Caicedo LM
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(6):418-419. PubMed ID: 37422261
    [No Abstract]   [Full Text] [Related]  

  • 9. A rare case of Castleman disease mimicking a pancreatic tumor.
    Gülmez S; Keklikkıran ZZ; Ölmez T; Barışık NÖ
    Ann Ital Chir; 2019 Dec; 8():. PubMed ID: 31894755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Follicular dendritic sarcoma within a focus of Castleman's disease. Serial FDG PET/CT in the follow up of recurrence with histopathologic confirmation.
    Iagaru A; Mari C; Sam Gambhir S
    Rev Esp Med Nucl; 2007; 26(1):40-5. PubMed ID: 17286947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Castleman's disease. Large retroperitoneal masses and multiple calcifications detected by
    Xiao L; Zhu HM; Li L
    Hell J Nucl Med; 2019; 22(3):220-221. PubMed ID: 31587031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraneoplastic Pemphigus Associated With Castleman Disease Detected by 18F-FDG PET/CT.
    Fu Z; Liu M; Chen X; Yang X; Li Q
    Clin Nucl Med; 2018 Jun; 43(6):464-465. PubMed ID: 29561527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A huge retroperitoneal Castleman's disease - rare entity.
    Jaishanker S; D'Cruze L; Muralidharan S; Gunabooshanam B; Singh KB
    J Cancer Res Ther; 2023 Jan; 19(Suppl 2):S980-S982. PubMed ID: 38384096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 10-year observational single-center study of retroperitoneal unicentric Castleman disease.
    Wang W; Dong D; Wen J; Li H
    Medicine (Baltimore); 2021 Mar; 100(10):e25088. PubMed ID: 33725899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET/CT imaging with 18F-FDG in Castleman disease.
    Delgado A; Mesa J; Guayambuco S; Rodriguez T; Fernández I; Rodeño E
    Rev Esp Med Nucl Imagen Mol; 2016; 35(3):200-1. PubMed ID: 26614744
    [No Abstract]   [Full Text] [Related]  

  • 16. FDG positron emission tomographic scintigraphy can reveal Castleman's disease as a cause of inflammation.
    Blockmans D; Maes A; Stroobants S; Bobbaers H; Mortelmans L
    Clin Nucl Med; 2001 Nov; 26(11):975-6. PubMed ID: 11595872
    [No Abstract]   [Full Text] [Related]  

  • 17.
    He L; Chen Y; Tan X; Sun X; Zhang Q; Luo H; Jiang L
    Jpn J Radiol; 2023 Jan; 41(1):98-107. PubMed ID: 35895223
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Fernández-Rodríguez P; Fernández López R; Acevedo Báñez I; Mohigefer Barrera J; Jiménez-Hoyuela García JM
    Eur J Nucl Med Mol Imaging; 2020 Jan; 47(1):222-223. PubMed ID: 31494704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 99mTc-HYNIC-TOC scintigraphy is superior to 131I-MIBG imaging in the evaluation of extraadrenal pheochromocytoma.
    Chen L; Li F; Zhuang H; Jing H; Du Y; Zeng Z
    J Nucl Med; 2009 Mar; 50(3):397-400. PubMed ID: 19223405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Somatostatin receptor scintigraphy using 99mTc-EDDA/HYNIC-TOC in patients with medullary thyroid carcinoma.
    Czepczyński R; Parisella MG; Kosowicz J; Mikołajczak R; Ziemnicka K; Gryczyńska M; Sowiński J; Signore A
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1635-45. PubMed ID: 17530247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.